ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials in Scottsdale, Arizona

Find clinical trials in Scottsdale, Arizona. Discover local research opportunities and treatment options in your area.

437 Active Trials Found in Scottsdale

Showing 437 trials on this page

Page 1 of 22

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting
Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

NCT ID: NCT06321575

The GREAT Trial is studying the Golazo® Peripheral Atherectomy System, which is a device used to treat patients with Peripheral Arterial Disease (PAD) in their legs. The goal of the trial is to ens...

Recruiting
Phase: NA Conditions: Peripheral Arterial Disease

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

NCT ID: NCT06778863

This clinical trial is studying a new treatment called CLSP-1025 for adults with certain types of solid tumors that have a specific genetic mutation known as p53 R175H. These tumors can include adv...

Recruiting
Phase: PHASE1 Conditions: Breast Cancer, Prostate Cancer +9 more

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

NCT ID: NCT06806592

This clinical trial is studying a medication called nerandomilast to see if it can help improve lung function in adults with lung fibrosis related to certain autoimmune diseases, like rheumatoid ar...

Not yet recruiting
Phase: PHASE3 Conditions: Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT ID: NCT03866382

This clinical trial is investigating how well three medications—cabozantinib, nivolumab, and ipilimumab—work together to treat patients with rare genitourinary tumors that have spread to other part...

Recruiting
Phase: PHASE2 Conditions: Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 +43 more

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

NCT ID: NCT04164082

This clinical trial is examining whether adding an anti-cancer drug called pembrolizumab to the standard chemotherapy treatment, gemcitabine, can help patients with non-muscle invasive bladder canc...

Recruiting
Phase: PHASE2 Conditions: Stage I Bladder Cancer AJCC v8, Stage 0a Bladder Cancer AJCC v8 +3 more

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

NCT ID: NCT04402788

The RAPTOR Trial is a clinical study looking at whether adding radiation therapy to the usual treatment with atezolizumab can help patients with extensive stage small cell lung cancer. This type of...

Recruiting
Phase: PHASE2 Conditions: Extensive Stage Lung Small Cell Carcinoma

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

NCT ID: NCT05754957

This clinical trial is studying a medication called milvexian to see if it can help reduce the risk of serious heart problems in patients who have recently experienced an acute coronary syndrome (A...

Recruiting
Phase: PHASE3 Conditions: Acute Coronary Syndrome

Nectero EAST System Clinical Study

NCT ID: NCT06001918

The Nectero EAST System Clinical Study is a research trial aimed at helping patients with small to mid-sized abdominal aortic aneurysms (AAAs), which are bulges in a major blood vessel in the abdom...

Recruiting
Phase: PHASE2 Conditions: Abdominal Aortic Aneurysm

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

NCT ID: NCT06817356

This clinical trial is studying a new treatment called mazdutide for people who have Alcohol Use Disorder (AUD), which means they have a strong dependence on alcohol. The goal of the study is to se...

Recruiting
Phase: PHASE2 Conditions: Alcohol Use Disorder

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

NCT ID: NCT04396236

This clinical trial is studying a medication called lasmiditan to see if it is safe and effective for children aged 6 to 17 who suffer from migraines. The researchers want to find out if this treat...

Recruiting
Phase: PHASE3 Conditions: Migraine

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

NCT ID: NCT04396574

This clinical trial is studying a medication called lasmiditan to see if it is safe and effective for treating migraines in children aged 6 to 17. The study will last for 12 months and will include...

Recruiting
Phase: PHASE3 Conditions: Migraine

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

NCT ID: NCT05063162

This clinical trial is studying a new treatment called rozanolixizumab for adults with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD). The main goal is to see how well thi...

Recruiting
Phase: PHASE3 Conditions: Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

NCT ID: NCT05723198

This clinical trial is studying a medication called baricitinib to see if it can help children aged 6 to under 18 who have severe hair loss due to a condition called alopecia areata. The main goal ...

Recruiting
Phase: PHASE3 Conditions: Skin Diseases, Alopecia +4 more

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting
Phase: PHASE3 Conditions: Hidradenitis Suppurativa

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

NCT ID: NCT06131840

This clinical trial is investigating an experimental drug called PF-08046050, which is designed to treat adults with advanced solid tumors, including types of cancer like colorectal, stomach, pancr...

Recruiting
Phase: PHASE1 Conditions: Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms +4 more

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

NCT ID: NCT06143956

This clinical trial, called LY900038, is looking to find safe and effective ways to help adults with obesity or who are overweight manage their weight long-term. It is a Phase-2 study, which means ...

Recruiting
Phase: PHASE2 Conditions: Obesity, Overweight

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting
Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

NCT ID: NCT06558279

This clinical trial is studying a new treatment called efgartigimod PH20 SC for adults with ocular myasthenia gravis, a condition that affects the eye muscles and can cause drooping eyelids and dou...

Recruiting
Phase: PHASE3 Conditions: Myasthenia Gravis, Ocular

A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06603077

This clinical trial is investigating a new treatment called AVTX-009 for patients with moderate to severe Hidradenitis Suppurativa (HS), a skin condition that causes painful lumps and sores. The go...

Recruiting
Phase: PHASE2 Conditions: Hidradenitis Suppurativa
Search All Trials Browse All Locations